site banner
Jump in the discussion.

No email address required.

I don't think that NIH wants to be in the Eugenics business, so they're taking steps to avoid it.

  • -22

If an organization is "in the X business" just because data it produces could, by some third party, be used to justify X, isn't funding something could cause Y an even stronger connection? Yet NIH funded viral research in Wuhan, increasing the risk of a global pandemic.

You could broadly say that NIH wants to be in the germs business but not the make people smarter business.

It's looking more and more like genetic engineering is the only viable way to close racial SES gaps. Ironically, the NIH is fighting to preserve racial inequalities while proclaiming its intent to narrow them.